The first case of ethanol sclerotherapy in 1998. Management of recurrent endometriosis after TAH+BSO – report of three cases

Pratibha Devabhaktuni; Savitha Devi Yelamanchi; Mahjabeen Singh

doi:10.18203/2320-1770.ijrcog20261480

Authors

Pratibha Devabhaktuni Department of Obstetrics and Gynaecology, Modern Government Maternity Hospital, Osmania Medical College, Hyderabad, Telangana, India
Savitha Devi Yelamanchi Swapna Health Care, Hyderabad, Telangana, India
Mahjabeen Singh Department of Imageology, Interventional Sonologist, Swapna Health Care, Begumpet, Hyderabad, Telangana, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20261480

Keywords:

Endometriosis recurrence, Ethanol sclerotherapy, ERT, Endometriotic cyst

Abstract

The first case of Ethanol sclerotherapy (EST) in 1998. Management of Recurrent Endometriosis after TAH+BSO, three cases are presented. The objective is to bring to focus the pitiable plight of these women suffering from severe pain abdomen prior to surgery and again after surgery due to recurrent disease. The dilemma of the doctor in deciding the best possible method of managing these cases. To present the different methods adopted to alleviate the pain and treat recurrences three decades ago. To discuss the current management trends. Case Report 1: Mrs. L. 46 years P2 L2 was operated for stage IV endometriosis. TAH+BSO was done on 5.2.96. A scan was done on 27.7.97 revealed an endometriotic cyst in the pelvis, 4.9x4.8 cms and 40 ml of thick chocolate material was aspirated vaginally. Ethanol, 5 ml was injected in the cyst. By three months there was reformation of endometrioma and a repeat second aspiration was done. Danazol 400 mgs/day, in divided doses was given for three months. Two years after TAH+BSO, third time aspiration of 7 ml thick chocolate liquid was done from 2 cms cyst and 4 ml spirit, absolute alcohol was injected on 15.1.98. We present our first case of ethanol sclerotherapy to treat recurrent endometriotic cyst after hysterectomy and bilateral salpingo oophorectomy in 1996-1998. In two other cases ERT had resulted in early recurrence of endometriosis, hence should be avoided. Endometriosis being a recurrent disease, the management decisions had to be individualized. We have discussed about Ethanol sclero therapy, reasons for recurrence after TAH+BSO, and the side effects of Danazol.

Metrics

Metrics Loading ...

References

Martin DC. Hysterectomy for treatment of pain associated with endometriosis. J Minim Invasive Gynecol 2006;13:566-72.

Namnoum AB, Hickman TN, Goodman SB, Gehlbach DL, Rock JA. Incidence of symptom recurrence after hysterectomy for endometriosis. Fertil Steril. 1995;64:898-902.

Sandström A, Bixo M, Johansson M, Bäckström T, Turkmen S. Effect of hysterectomy on pain in women with endometriosis: a population-based registry study. Bjog. 2020;127:1628-35.

Meuleman C, Tomassetti C, D'Hoore A, Van Cleynenbreugel B, Penninckx F, Vergote I, et al. Surgical treatment of deeply infiltrating endometriosis with colorectal involvement. Hum Reprod Update. 2011;17(3):311-26.

Akgün N, Sarıdoğan E. Management of menopause in women with a history of endometriosis. J Turk Ger Gynecol Assoc. 2024;25(2):107-11.

National Institute for Health and Care Excellence (NICE). Menopause: identification and management. London: NICE. 2024. Available at: https://www.nice.org.uk/guidance/ng23. Accessed on 06 April 2026.

Akamatsu N, Hirai T, Masaoka H, Sekiba K, Fujita T. Ultrasonically guided puncture of endometrial cysts: aspiration of contents and infusion of ethanol. Nihon Sanka Fujinka Gakkai Zasshi. 1988;40(2):187-91.

Agostini A, De Lapparent T, Collette E, Capelle M, Cravello L, Blanc B. In situ methotrexate injection for treatment of recurrent endometriotic cysts. Eur J Obstet Gynecol Reprod Biol. 2007;130(1):129-31.

Gonçalves FC, Andres MP, Passman LJ, Gonçalves MO, Podgaec S. A systematic review of ultrasonography-guided transvaginal aspiration of recurrent ovarian endometrioma. Int J Gynaecol Obstet. 2016;134(1):3-7.

Albanese G, Kondo KL. Pharmacology of sclerotherapy. Semin Intervent Radiol. 2010;27(4):391-9.

Cohen A, Almog B, Tulandi T. Sclerotherapy in the management of ovarian endometrioma: systematic review and meta-analysis. Fertil Steril. 2017;108(1):117-24.

Ronsini C, Iavarone I, Braca E, Vastarella MG, De Franciscis P, Torella M. The efficiency of sclerotherapy for the management of endometrioma: a systematic review and meta-analysis of clinical and fertility outcomes. Medicina (Kaunas). 2023;59(9):1643.

Castellarnau Visus M, Ponce Sebastia J, Carreras Collado R, Cayuela Font E, Garcia Tejedor A. Preliminary results: ethanol sclerotherapy after ultrasound-guided fine needle aspiration without anesthesia in the management of simple ovarian cysts. J Minim Invasive Gynecol. 2015;22(3):475-82.

Younis JS, Shapso N, Izhaki I, Taylor HS. Ethanol sclerotherapy for management of endometriomas: an overview of systematic reviews. Front Endocrinol (Lausanne). 2025;16:1612899.

Sükür YE, Aslan B, Varlı B, Özcan P, Daniilidis A, Kalaitzopoulos DR. Ethanol sclerotherapy for endometriomas in infertile women: a narrative review. J Clin Med. 2024;13(24):7548.

Lentzaris D, Gkrozou F, Skentou C, Angelidis P, Theodosiadis N, Kalampokas T. Future of sclerotherapy in the treatment of endometriosis: a narrative literature review. Cureus. 2025;17(3):e81215.

Miquel L, Preaubert L, Gnisci A, Resseguier N, Pivano A, Perrin J, et al Endometrioma ethanol sclerotherapy could increase IVF live birth rate in women with moderate-severe endometriosis. PLoS One. 2020;15:e0239846.

Rizk B, Fischer AS, Lotfy HA, Turki R, Zahed HA, Malik R, et al. Recurrence of endometriosis after hysterectomy. Facts Views Vis Obgyn. 2014;6(4):219-27.

Gemmell LC, Webster KE, Kirtley S, Vincent K, Zondervan KT, Becker CM. The management of menopause in women with a history of endometriosis: a systematic review. Hum Reprod Update. 2017;23(4):481-500.

Amer S, Bazmi S. HRT in women undergoing pelvic clearance for endometriosis—a case report and a national survey. J Clin Med. 2023;12(1):336.

As-Sanie S, Till SR, Schrepf AD, Griffith KC, Tsodikov A, Missmer SA, et al. Incidence and predictors of persistent pelvic pain following hysterectomy in women with chronic pelvic pain. Am J Obstet Gynecol. 2021;225(5):e1-568.

Brunes M, Johannesson U, Häbel H, Forsgren C, Moawad G, Ek M. Peri- and postoperative outcomes in patients with endometriosis undergoing hysterectomy. Eur J Obstet Gynecol Reprod Biol. 2022;272:104-9.

Fuldeore MJ, Chwalisz K, Marx S, Wu N, Boulanger L, Ma L, et al. Surgical procedures and their cost estimates among women with newly diagnosed endometriosis: a US database study. J Med Econ. 2011;14(1):115-23.

Hamoda H, Moger S, Morris E, Baldeweg SE, Kasliwal A, Gabbay F. Menopause practice standards. Clin Endocrinol (Oxf). 2022;97(6):809-14.

Soliman NF, Hillard TC. Hormone replacement therapy in women with past history of endometriosis. Climacteric. 2006;9(4):325-35.

Kitawaki J, Kado N, Ishihara H, Koshiba H, Kitaoka Y, Honjo H. Endometriosis: the pathophysiology as an estrogen-dependent disease. J Steroid Biochem Mol Biol. 2002;83(5):149-55.

Bulun SE, Monsavais D, Pavone ME, Dyson M, Xue Q, Attar E, et al. Role of estrogen receptor-beta in endometriosis. Semin Reprod Med. 2012;30(1):39-45.

Hamoda H. British Menopause Society Medical Advisory Council. British Menopause Society tools for clinicians: progestogens and endometrial protection. Post Reprod Health. 2022;28(1):40-6.

Becker CM, Bokor A, Heikinheimo O, Horne A, Jansen F, Kiesel L, et al. ESHRE guideline: endometriosis. Hum Reprod Open. 2022;2022(2):hoac009.

Fournier A, Berrino F, Clavel-Chapelon F. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat. 2008;107(1):103-11.

Asi N, Mohammed K, Haydour Q, Gionfriddo MR, Vargas OL, Prokop LJ, et al. Progesterone vs synthetic progestins and the risk of breast cancer: a systematic review and meta-analysis. Syst Rev. 2016;5:121.